WellPoint affiliate ordered to pay $206K for transplant

Back to TopCommentsE-mailPrintBookmark and Share

Blue Cross of California, a subsidiary of Indianapolis-based WellPoint Inc., has been ordered to reimburse a man $206,000 after he paid for his own liver transplant.

Ephram Nehme (EH'-from NEH'-mee) sued his health insurer to pay for an out-of-state liver transplant, saying he would have died while waiting to have his surgery at a Blue Cross-approved hospital in California.

Blue Cross approved the liver transplant to be performed at UCLA Medical Center in 2006, but his doctor recommended he travel to Clarian Transplant Center in Indiana because the wait times there were much shorter. The 62-year-old paid for the transplant out of pocket in 2007.

Nehme was denied payment in three appeals to the company before Monday's award.

The court also found Blue Cross acted without malice in the denial of payment.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ